跳至主要内容
临床试验/NCT00745849
NCT00745849已完成不适用

Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial

University of Texas Southwestern Medical Center1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2005年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
43
试验地点
1
主要终点
Total Nasal Symptom Scores

研究概览

简要总结

The purpose of this study was to see if high dose esomeprazole (40mg bid) was effective in treating non-allergic rhinitis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age between 18-80, symptoms of perennial rhinitis, negative epicutaneous skin testing to a panel of common aeroallergens, and ability to speak English

排除标准

  • pregnancy or breast-feeding, evidence of positive skin tests to a common aeroallergen, treatment with a proton pump inhibitor within the month prior to enrollment, treatment with any other anti-reflux therapy within the last month on a daily basis or within the last two weeks on an as needed basis, and other gastrointestinal disorders leading to reflux symptoms

研究组 & 干预措施

1

Experimental

esomeprazole 40mg po bid

干预措施: esomeprazole (Drug)

2

Placebo Comparator

干预措施: placebo (Drug)

结局指标

主要结局

Total Nasal Symptom Scores

时间窗: Last two weeks of each treatment arm

(1=none, 7=unbearably severe) difference in nasal symptom scores for the average of the last two weeks of each treatment arm

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dave Khan

Professor of Internal Medicine

University of Texas Southwestern Medical Center

研究点 (1)

Loading locations...

相似试验